Bio-Thera Solutions, the developer of the biosimilar, will continue to hold manufacturing rights in the US market.

Originally approved by the FDA in September 2023, Biogen's Tofidence became the first tocilizumab biosimilar available in the ...

Organon’s workforce cuts come several months after the company’s loss of exclusivity to its second-largest product, Atozet.

Britain’s government is placing Russia on the top tier of a government security program aimed at protecting the U.K. from malign foreign influence. Home Office minister Dan Jarvis said anyone ...

Kendrick Lamar, Gracie Abrams, Zoe Saldaña and Nutter Butter are among the nominees for this year’s Webby Awards, recognizing the best internet content and creators. The International Academy of Digit ...

Organon (OGN) stock in focus as the Merck (MRK) spinoff buys rights to Biogen's (BIIB) biosimilar Tofidence, targeting ...

Tofidence is indicated in certain patients for the treatment of moderate to severe rheumatoid arthritis, giant cell arteritis ...

Organon (OGN) announced that it has acquired from Biogen (BIIB) regulatory and commercial rights in the U.S. for Tofidence, a biosimilar to ...